Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 2,482,000 $ 14,533,000
Accounts receivable 6,134,000 6,328,000
Prepaid expense and other current assets 1,381,000 1,334,000
Total current assets 9,997,000 22,195,000
Property and Equipment, net 147,000 104,000
Intangible and Other Assets, net 20,066,000 24,243,000
Goodwill 0 50,263,000
Total assets 30,210,000 96,805,000
Current Liabilities    
Accounts payable 6,697,000 5,514,000
Accrued contingent consideration (Note 5) 3,206,000 0
Deferred revenue 111,000 76,000
Convertible note payable and accrued interest (Note 6) 679,000 0
Total current liabilities 10,693,000 5,590,000
Deferred taxes 313,000 518,000
Total liabilities 11,006,000 6,108,000
Commitments and Contingencies  
Stockholders’ Equity    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; 10,323 and no shares issued and outstanding as of December 31, 2022 and 2021, respectively (Note 7). 0 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 37,605,973 and 36,809,187 shares issued and outstanding as of December 31, 2022 and 2021, respectively. 47,000 46,000
Additional paid-in capital 229,900,000 215,943,000
Accumulated deficit (210,743,000) (125,292,000)
Total stockholders’ equity 19,204,000 90,697,000
Total liabilities and stockholders’ equity $ 30,210,000 $ 96,805,000